Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
- PMID: 31377781
- PMCID: PMC8414923
- DOI: 10.1093/rheumatology/kez292
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
Erratum in
-
Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort.Rheumatology (Oxford). 2020 Mar 1;59(3):698. doi: 10.1093/rheumatology/kez516. Rheumatology (Oxford). 2020. PMID: 31630173 Free PMC article. No abstract available.
Abstract
Objective: Damage in patients with systemic lupus erythematosus is irreversible change in organs due to disease activity, concomitant disease or medication side-effects. It is measured using the Systemic Lupus International Collaborative Clinics Damage Index (SDI) and is associated with increased mortality. Previous reports have suggested associations between damage accrual and various ethnic, disease and treatment factors, but there is a dearth of long-term follow-up data from large multi-ethnic cohorts. We describe a study of damage and mortality in 300 patients from London, UK followed for up to 40 years.
Methods: We carried out retrospective analysis of medical records and SDI scores of 300 patients followed for up to 40 years (median 13.3 years). Characteristics of the groups who did and did not develop damage and those who died or survived to the end of follow-up were compared using univariable and multivariable analysis. Kaplan-Meier analysis was used to analyse factors affecting mortality and accrual of damage.
Results: Damage developed in 231/300 (77%) of patients. There was a linear accrual of damage over 40 years follow-up. Factors associated with damage were African/Caribbean ethnicity, renal and cerebral involvement, early use of high-dose corticosteroids or immunosuppressants, anti-RNP and antiphospholipid antibodies. Damage was strongly associated with mortality. Of 87 patients who died, 93% had damage compared with 70% of survivors (P < 0.001).
Conclusion: Development of damage is strongly associated with increased mortality. We identified groups at increased risk of developing damage, including those treated with high-dose steroids and immunosuppressants within the first two years.
Keywords: Systemic lupus erythematosus; damage; mortality.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Figures
References
-
- Kasitanon N, Magder LS, Petri M.. Predictors of survival in systemic lupus erythematosus. Medicine 2006;85:147–56. - PubMed
-
- Wada Y, Hasegawa H, Saeki T. et al.Long-term prognosis and factors associated with damage accrual in Japanese patients with systemic lupus erytehamtosus. Clin Exp Nephrol 2018;22:597–602. - PubMed
-
- Gladman D, Ginzler E, Goldsmith C. et al.The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363–9. - PubMed
-
- Sutton EJ, Davidson JE, Bruce IN.. The Systemic Lupus International Collaborating Clinics (SLICC) Damage Index: a systematic literature review. Semin Arthritis Rheum 2013;43:352–61. - PubMed
-
- Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS.. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001;10:93–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
